At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
Zenith® Dissection Endovascular Graftdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Zenith® Dissection Endovascular System
In Brief
A clinical study evaluating Zenith® Dissection Endovascular Graft for Aortic Dissection. Completed, enrolled 26 participants across 5 sites.
Detailed Summary
The Zenith® Dissection Clinical Trial is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® Dissection Endovascular System in the treatment of patients with aortic dissection.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Dissection
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2007
Primary CompletionFeb 2012
First PostedMar 2014
Study CompletionNov 2016
TodayJul 2026
First PostedMar 21, 2014
Enrollment StartDec 1, 2007
Primary CompletionFeb 1, 2012
Study CompletionNov 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 12.3 years ago
Interventions
Zenith® Dissection Endovascular Graftdevice
Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guide the study device(s) into place in the aorta.